RxDoctor Payments Data

Carmel Fratianni

Endocrinology, Diabetes & Metabolism · Media, PANPI 1033106828

Payments from drug & device makers

$1,348in general payments, 2019–2025

Across 87 payments — averaging $15.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$338
  • Medtronic$234
  • Novo Nordisk$115
  • Sanofi-aventis U.S. LLC$93
  • AstraZeneca$83
  • Xeris Pharmaceuticals, Inc.$69
  • plus $417 from 13 others

What the payments were for

  • Food & beverage$1,348100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,348 in reported general payments places this provider in the 50th percentile of 388 endocrinology, diabetes & metabolism providers in Pennsylvania.

See all endocrinology, diabetes & metabolism providers in Pennsylvania

Other endocrinology, diabetes & metabolism in Media

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →